Article
DREADDs suppress seizure-like activity in a mouse model of pharmacoresistant epileptic brain tissue.
Gene therapy - 1 Oct 2016
Avaliani N, Andersson M, Runegaard A H, Woldbye D, Kokaia M
Abstract excerpt
Epilepsy is a neurological disorder with a prevalence of ≈1% of general population. Available antiepileptic drugs (AEDs) have multiple side effects and are ineffective in 30% of patients. Therefore, development of effective treatment strategies is highly needed, requiring drug-screening models that are relevant and reliable. We investigated novel chemogenetic approach, using DREADDs (designer receptors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
